Atıf İçin Kopyala
ÖZ GÜL Ö., Kiyici S., ERSOY C., CANDER S., Yorulmaz H., Gul C. B., ...Daha Fazla
DIABETES RESEARCH AND CLINICAL PRACTICE, cilt.94, sa.2, ss.212-216, 2011 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
94
Sayı:
2
-
Basım Tarihi:
2011
-
Doi Numarası:
10.1016/j.diabres.2011.07.031
-
Dergi Adı:
DIABETES RESEARCH AND CLINICAL PRACTICE
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.212-216
-
Anahtar Kelimeler:
Sitagliptin, Diabetes mellitus type 2, Ghrelin, Body weight, INCRETIN-BASED THERAPIES, CIRCULATING GHRELIN, INSULIN THERAPY, WEIGHT-GAIN, METFORMIN, INHIBITOR, STOMACH, PEPTIDE
-
Bursa Uludağ Üniversitesi Adresli:
Evet
Özet
Aim: Sitagliptin is not associated with weight gain and has neutral effects on body weight. It is unclear whether sitagliptin treatment alters serum ghrelin levels in people with type 2 diabetes.